Back to 
Federated Hermes, Inc.
Federated Hermes, Inc.
PDSB
Showing 0 of 13 quarters
Position history for Federated Hermes, Inc.'s holdings in PDS Biotechnology Corporation
No. Federated Hermes exited its PDSB (PDS Biotechnology) position in Q2 2023. Its Q1 2023 13F listed 123 shares worth $756. Federated Hermes first reported PDSB in Q1 2020 and held it in 10 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.